In the last trading session, 3,360,778 shares of the InVivo Therapeutics Holdings Corp.(NASDAQ:NVIV) were traded, and its beta was 1.84. Most recently the company’s share price was $1.42, and it changed around -$0.11 or -0.07% from the last close, which brings the market valuation of the company to $30.06 Million. NVIV currently trades at a discount to its 52-week high of $7.85, offering almost -452.82% off that amount. The share price’s 52-week low was $0.5, which indicates that the current value has risen by an impressive 64.79% since then. We note from InVivo Therapeutics Holdings Corp.’s average daily trading volume that its 10-day average is 8.09 Million shares, with the 3-month average coming to 5.95 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

InVivo Therapeutics Holdings Corp. stock received a consensus recommendation rating of Buy, based on a mean score of 0. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended NVIV as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. InVivo Therapeutics Holdings Corp. is expected to report earnings per share of $0 for the current quarter.

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV): Trading Information

Although NVIV has showed a red trend with a performance of -7.19% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2 on Tuesday, Feb 16 increased the stock’s daily price by 29%. The company’s shares are currently up 0.75% year-to-date, but still down -0.0955 over the last five days. On the other hand, InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) is 0.01% up in the 30-day period. We can see from the shorts that 3.87 Million shares have been sold at a short interest cover period of 0.65 day(s).

The consensus price target as assigned by Wall Street analysts is $37.5, which translates to bears needing to increase their stock price by 2540.85% from its current value. Analyst projections state that NVIV is forecast to be at a low of $37.5 and a high of $37.5. In order for the stock price to hit the forecast high, the stock would need to surge +2540.85% from its current level, while the stock would need to crash 2540.85% from its current level to reach the projected low.

InVivo Therapeutics Holdings Corp. (NVIV) projections and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 43.7%. InVivo Therapeutics Holdings Corp. earnings are expected to increase by 74.9% in 2021, but the outlook is negative 0% per year for the next five years.

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)’s Biggest Investors

Upon looking at major shareholders, it appears that insiders hold 12.35% of InVivo Therapeutics Holdings Corp. shares, and 7.09% of them are in the hands of institutional investors. The stock currently has a share float of 8.09%. InVivo Therapeutics Holdings Corp. stock is held by 22 institutions, with Renaissance Technologies, LLC being the largest institutional investor. By Dec 30, 2020, it held 0.53% of the shares, which is about 111.47 Thousand shares worth $90.29 Thousand.

Wedbush Securities Inc, with 0.38% or 81.49 Thousand shares worth $115.72 Thousand as of Sep 29, 2020, holds the second largest percentage of outstanding shares.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

LEAVE A REPLY

Please enter your comment!
Please enter your name here